Selectis Health (OTCMKTS:GBCS) & Enhabit (NYSE:EHAB) Head-To-Head Comparison

Selectis Health (OTCMKTS:GBCS) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability.

Profitability

This table compares Selectis Health and Enhabit’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Selectis Health	-1.87%	N/A	-2.34%
Enhabit	-0.43%	4.71%	2.23%

Earnings & Valuation

This table compares Selectis Health and Enhabit”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Selectis Health	$39.49 million	0.31	-$2.42 million	($0.27)	-15.00
Enhabit	$1.06 billion	0.65	-$4.60 million	($0.09)	-151.28

Selectis Health has higher earnings, but lower revenue than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than Selectis Health, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and recommmendations for Selectis Health and Enhabit, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Selectis Health	0	0	0	0	0.00
Enhabit	1	6	2	0	2.11

Enhabit has a consensus price target of $13.57, indicating a potential downside of 0.32%. Given Enhabit’s stronger consensus rating and higher possible upside, analysts clearly believe Enhabit is more favorable than Selectis Health.

Risk and Volatility

Selectis Health has a beta of -1.03, suggesting that its share price is 203% less volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500.

Summary

Enhabit beats Selectis Health on 10 of the 12 factors compared between the two stocks.

About Selectis Health

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.

About Enhabit

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.